Cargando…
Determination of colistin-related nephrotoxicity and risk factors in intensive care unit
OBJECTIVE: Colistin is a cationic polypeptide antibiotic with a cyclic structure that belongs to the polymyxin group. It was banned from clinical use because of its significant renal side effects, such as nephrotoxicity. However, the administration of colistin has recently been initiated again in th...
Autores principales: | Inci, Ayse, Toker, Melike Korkmaz, Bicer, Ilhan Guney, Derbent, Abdurrrahim, Salihoglu, Ziya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191557/ https://www.ncbi.nlm.nih.gov/pubmed/30374477 http://dx.doi.org/10.14744/nci.2017.42243 |
Ejemplares similares
-
Evaluation of immunomodulatory nutrients in critically ill patients in the intensive care unit
por: Ay, Necmiye, et al.
Publicado: (2022) -
Evaluation of prognosis and nephrotoxicity in patients treated with colistin in intensive care unit
por: Gunay, Emrah, et al.
Publicado: (2020) -
Molecular Mechanisms of Colistin-Induced Nephrotoxicity
por: Gai, Zhibo, et al.
Publicado: (2019) -
Does dexmedetomidine prevent colistin nephrotoxicity?
por: Talih, Gamze, et al.
Publicado: (2018) -
The risk factors of colistin methanesulfonate associated nephrotoxicity
por: Tigen, Elif Tükenmez, et al.
Publicado: (2016)